Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bromide-sensitive neuronal inhibitory channels primarily refer to the Gamma-aminobutyric acid type A (GABA-A) receptor and the glycine receptor, which are ligand-gated ion channels that mediate fast inhibitory neurotransmission in the central nervous system (PubMed: 11578307). These channels typically conduct chloride ions (Cl-), but they are also highly permeable to bromide ions (Br-), which can substitute for or supplement chloride to induce membrane hyperpolarization (StatPearls: NBK545210). By increasing the total inhibitory charge transfer, bromide effectively raises the threshold for neuronal firing, which underlies its historical and continued use as an antiepileptic agent, particularly in veterinary medicine and refractory human cases (NCBI: PMC3611655). The interaction of bromide with these channels does not require a specific binding site like benzodiazepines; rather, it relies on the physical permeability of the ionophore to the bromide ion itself. Chronic activation or high concentrations of bromide can lead to "bromism," a toxic state characterized by neurological and psychiatric symptoms, highlighting the narrow therapeutic index of targeting these channels with bromide salts (NIH: PubChem CID 255).
Bromide ions permeate the GABA-A and glycine receptor channels, often with higher permeability than chloride ions, leading to increased inhibitory postsynaptic potentials and neuronal hyperpolarization (PubMed: 11578307).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A receptor (GABA-A receptor) (GABA-A receptor).